Kate Lorig

Last updated
Dr. Kate Lorig
Born1942
Education Boston University (B.S. Nursing), University of California, San Francisco (M.S. Nursing), University of California, Berkeley (Ph.D.)
Occupation registered nurse
Known forAuthor, work on chronic disease and patient education

Dr. Kate Lorig, Dr.P.H., is an American professor at the Stanford University School of Medicine. She is also the director of the Stanford Patient Education Research Center. She is known for her work on chronic disease and patient education, has published several books and peer-reviewed journal articles in those fields, and developed a peer-led self-management course for patients with chronic diseases. Lorig is herself a chronic disease patient, having been diagnosed with Gaucher's disease at the age of three. [1]

Contents

Lorig received her B.S. in nursing at Boston University in 1964, her M.S. in nursing at the University of California, San Francisco in 1968, and her Dr.P.H. in health education at the University of California, Berkeley in 1980. Lorig joined Stanford Medical School in 1978 as a research associate, becoming a professor in 1995. She has been a professor at the UCSF School of Nursing since 1985, and was a lecturer at San Jose State University, Department of Health Sciences, from 1980 to 1989. [2]

Kaiser Permanente adopted the Chronic Disease Self Management (CDSM) course in 1997. [3] In 2001, the CDSM and Lorig's arthritis specific self-management courses were included in the United Kingdom National Health Service's Expert Patient Programme, on a trial basis. The program, and Lorig's courses, were adopted into the mainstream of the NHS beginning in 2004. [1] In 2007, Dr. Lorig worked with the VA Desert Pacific Health Care Network/Department of Veteran Affairs to develop a pilot online self-management model for family caregivers based on her previous work.

Lorig is a member of the Network of Innovators of the World Health Organization's Observatory on Health Care for Chronic Conditions. [4] She received the Molly Mettler Award from the National Council on Aging's Health Promotion Institute in 2003. [5]

Post-degree honors and awards

Selected publications

Related Research Articles

Disease management is defined as "a system of coordinated healthcare interventions and communications for populations with conditions in which patient self-care efforts are significant."

The term diabetes includes several different metabolic disorders that all, if left untreated, result in abnormally high concentrations of a sugar called glucose in the blood. Diabetes mellitus type 1 results when the pancreas no longer produces significant amounts of the hormone insulin, usually owing to the autoimmune destruction of the insulin-producing beta cells of the pancreas. Diabetes mellitus type 2, in contrast, is now thought to result from autoimmune attacks on the pancreas and/or insulin resistance. The pancreas of a person with type 2 diabetes may be producing normal or even abnormally large amounts of insulin. Other forms of diabetes mellitus, such as the various forms of maturity-onset diabetes of the young, may represent some combination of insufficient insulin production and insulin resistance. Some degree of insulin resistance may also be present in a person with type 1 diabetes.

A chronic condition is a health condition or disease that is persistent or otherwise long-lasting in its effects or a disease that comes with time. The term chronic is often applied when the course of the disease lasts for more than three months. Common chronic diseases include diabetes, functional gastrointestinal disorder, eczema, arthritis, asthma, chronic obstructive pulmonary disease, autoimmune diseases, genetic disorders and some viral diseases such as hepatitis C and acquired immunodeficiency syndrome. An illness which is lifelong because it ends in death is a terminal illness. It is possible and not unexpected for an illness to change in definition from terminal to chronic. Diabetes and HIV for example were once terminal yet are now considered chronic due to the availability of insulin for diabetics and daily drug treatment for individuals with HIV which allow these individuals to live while managing symptoms.

<span class="mw-page-title-main">Self-care</span> Taking care of ones own health

Self-care has been defined as the process of establishing behaviors to ensure holistic well-being of oneself, to promote health, and actively manage illness when it occurs. Individuals engage in some form of self-care daily with food choices, exercise, sleep, reading and dental care. Self-care is not only a solo activity as the community—a group that supports the person performing self-care—overall plays a large role in access to, implementation of, and success of self-care activities.

A nurse-led clinic is any outpatient clinic that is run or managed by registered nurses, usually nurse practitioners or Clinical Nurse Specialists in the UK. Nurse-led clinics have assumed distinct roles over the years, and examples exist within hospital outpatient departments, public health clinics and independent practice environments.

<span class="mw-page-title-main">Patient education</span>

Patient education is a planned interactive learning process designed to support and enable expert patients to manage their life with a disease and/or optimise their health and well-being.

<span class="mw-page-title-main">HLA-DR4</span>

HLA-DR4 (DR4) is an HLA-DR serotype that recognizes the DRB1*04 gene products. The DR4 serogroup is large and has a number of moderate frequency alleles spread over large regions of the world.

Chronic care management encompasses the oversight and education activities conducted by health care professionals to help patients with chronic diseases and health conditions such as diabetes, high blood pressure, systemic lupus erythematosus, multiple sclerosis, and sleep apnea learn to understand their condition and live successfully with it. This term is equivalent to disease management for chronic conditions. The work involves motivating patients to persist in necessary therapies and interventions and helping them to achieve an ongoing, reasonable quality of life.

<span class="mw-page-title-main">Lifestyle medicine</span> Branch of medicine

Lifestyle medicine (LM) is a branch of medicine focused on preventive healthcare and self-care dealing with prevention, research, education, and treatment of disorders caused by lifestyle factors and preventable causes of death such as nutrition, physical inactivity, chronic stress, and self-destructive behaviors including the consumption of tobacco products and drug or alcohol abuse. The goal of LM is to improve individuals' health and wellbeing by applying the 6 pillars of lifestyle medicine (nutrition, regular physical activity, restorative sleep, stress management, avoidance of risky substances, and positive social connection) to prevent chronic conditions such as cardiovascular diseases, diabetes, metabolic syndrome and obesity. By focusing on these 6 areas to improve health, LM can prevent 80% of chronic illnesses and non-communicable diseases (NCD).

Disease or patient registries are collections of secondary data related to patients with a specific diagnosis, condition, or procedure, and they play an important role in post marketing surveillance of pharmaceuticals. Registries are different from indexes in that they contain more extensive data.

<span class="mw-page-title-main">Dana Goldman</span>

Dana Paul Goldman is the dean of the USC Price School of Public Policy, Leonard D. Schaeffer Chair and director of the University of Southern California Leonard D. Schaeffer Center for Health Policy and Economics, and Professor of Public Policy, Pharmacy, and Economics at the Price School and USC School of Pharmacy. He is also an adjunct professor of health services and radiology at UCLA, and a managing director and founding partner, along with Darius Lakdawalla and Tomas J. Philipson, at Precision Heath Economics, a health care consulting firm. Previously held positions include the director of the Bing Center for Health Economics, RAND Royal Center for Health Policy Simulation, and UCLA/RAND Health Services Research Postdoctoral Training Program.

Stephen Thomas Wegener is an American rehabilitation psychologist specializing in the psychology of pain management. His work seeks to improve function and reduce disability for persons with chronic illness and impairments, including occupational injuries, rheumatic disease, spinal cord injury or limb loss. He also develops cognitive-behavioral therapy and self-management to prevent or mitigate pain associated with disability, and examines psychological variables that can affect positive outcomes.

Pediatric psychology is a multidisciplinary field of both scientific research and clinical practice which attempts to address the psychological aspects of illness, injury, and the promotion of health behaviors in children, adolescents, and families in a pediatric health setting. Psychological issues are addressed in a developmental framework and emphasize the dynamic relationships which exist between children, their families, and the health delivery system as a whole.

Matthew H. Liang is a physician specializing in social rheumatology, Professor of Medicine at Harvard Medical School, Professor of Health Policy and Management at Harvard School of Public Health, and the Director of Special Projects of the Robert B. Brigham Arthritis and Musculoskeletal Diseases Clinical Research Center which he founded. At the Brigham and Women's Hospital he is Medical Director of Rehabilitation Services. He is a founding faculty of the Division of General Internal Medicine and Primary Care at the Brigham and Women's Hospital and a founding faculty of the Clinical Effectiveness Program at the Harvard School of Public Health and is a Study Director in the Veterans Administration Cooperative Studies Program.

Chronic disease in Northern Ontario is a population health problem. The population in Northern Ontario experiences worse outcomes on a number of important health indicators, including higher rates of chronic disease compared to the population in the rest of Ontario.

The Patient Activation Measure (PAM) is a commercial product which assesses an individual's knowledge, skill, and confidence for managing one's health and healthcare. Individuals who measure high on this assessment typically understand the importance of taking a pro-active role in managing their health and have the skills and confidence to do so.

Patient satisfaction is a measure of the extent to which a patient is content with the health care which they received from their health care provider.

The American Association of Clinical Endocrinology (AACE), formerly known as the American Association of Clinical Endocrinologists, is a professional community of physicians specializing in endocrinology, diabetes, and metabolism. AACE's mission is elevating clinical endocrinology to improve global health. The association is headquartered in Jacksonville, Florida, US.

Specialty pharmacy refers to distribution channels designed to handle specialty drugs — pharmaceutical therapies that are either high cost, high complexity and/or high touch. High touch refers to higher degree of complexity in terms of distribution, administration, or patient management which drives up the cost of the drugs. In the early years specialty pharmacy providers attached "high-touch services to their overall price tags" arguing that patients who receive specialty pharmaceuticals "need high levels of ancillary and follow-up care to ensure that the drug spend is not wasted on them." An example of a specialty drug that would only be available through specialty pharmacy is interferon beta-1a (Avonex), a treatment for MS that requires a refrigerated chain of distribution and costs $17,000 a year. Some specialty pharmacies deal in pharmaceuticals that treat complex or rare chronic conditions such as cancer, rheumatoid arthritis, hemophilia, H.I.V. psoriasis, inflammatory bowel disease (IBD) or Hepatitis C. "Specialty pharmacies are seen as a reliable distribution channel for expensive drugs, offering patients convenience and lower costs while maximizing insurance reimbursements from those companies that cover the drug. Patients typically pay the same co-payments whether or not their insurers cover the drug." As the market demanded specialization in drug distribution and clinical management of complex therapies, specialized pharma (SP) evolved.„ Specialty pharmacies may handle therapies that are biologics, and are injectable or infused. By 2008 the pharmacy benefit management dominated the specialty pharmacies market having acquired smaller specialty pharmacies. PBMs administer specialty pharmacies in their network and can "negotiate better prices and frequently offer a complete menu of specialty pharmaceuticals and related services to serve as an attractive 'one-stop shop' for health plans and employers."

<span class="mw-page-title-main">Beth Darnall</span> American scientist and pain psychologist

Beth Darnall is American scientist, pain psychologist, author, and Associate Professor of Anesthesiology, Perioperative and Pain Medicine at the Stanford University School of Medicine where she directs the Stanford Pain Relief Innovations Lab. From 2005 to 2012, Darnall was an assistant professor and associate professor at Oregon Health & Science University.

References

  1. 1 2 "Kate Lorig's Story: From Gauchers Disease to developing Self Management Courses Worldwide" Archived 2006-10-17 at the Wayback Machine ; October, 2003; Gauchers News; url accessed November 8, 2006
  2. Kate Lorig, R.N., Dr.P.H.; Stanford School of Medicine; url accessed November 8, 2006
  3. Carrie Sturrock (April 26, 2006); "Self-help for chronic ailments: Stanford model offers relief to sufferers when pills can't"; San Francisco Chronicle ; url accessed November 8, 2006
  4. Kate LORIG; World Health Organization; url accessed November 8, 2006
  5. "Lorig, Mockenhaupt Receive Award from HPI"; National Council on Aging; url accessed November 8, 2006